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The aim of our current special issue was to present a series
of original researches and reviews on recent advances in the
diagnosis, medical therapy, and surgical approaches of heart
failure.
As reported in the introductive review of Agnetti et al.,
cardiovascular disease is the leading cause of mortality in the
US and in westernized countries with ischemic heart disease
accounting for the majority of these deaths. Paradoxically,
the improvements in the medical and surgical treatments
of acute coronary syndromes are leading to an increasing
number of “survivors” who are then developing heart failure.
Despite considerable advances in its management, the gold
standard for the treatment of end-stage heart failure patients
remains heart transplantation. Nevertheless, this procedure
can be offered only to a small percentage of patients who
could benefit from a new heart due to the limited availability
of donor organs. The authors reported in this comprehensive
review the evaluation of the safety and efficacy of innovative
approaches in the diagnosis and treatment of patients refrac-
tory to standard medical therapy and excluded from cardiac
transplantation lists.
Among the studies included in this special issue, two of
them investigated specific pathogenic aspects of heart failure.
M. Kunin et al. studied the role of proinflammatory cytokines
in congestive heart failure. In particular the authors evalu-
ated the effect of peritoneal dialysis used in the long-term
management of these patients on the peripheral-circulating
levels of these cytokines. Interestingly, they found that peri-
toneal dialysis treatment caused a reduction in circulating
inflammatory cytokines levels along with improvement in
plasma markers of inflammation in patients with refractory
chronic heart failure, concluding that this effectmay be partly
responsible for the efficacy of peritoneal dialysis for refractory
heart failure.
It is described that heart failure is accompanied by
the development of an imbalance between oxygen- and
nitric oxide-derived free radical production leading to
protein nitration. To cast further light on this issue, A.
Cabassi et al. investigated the relationship between plasma
myeloperoxidase-related chlorinating activity, ceruloplas-
min, and ferroxidase I and nitrosative stress and inflamma-
tory, neurohormonal, and nutritional biomarkers in heart
failure patients.This elegant study supported the conclusions
that plasmamyeloperoxidase chlorinated activity is increased
in elderly patients who suffer from chronic heart failure and
positively associated with ceruloplasmin and inflammatory,
neurohormonal, and nitrosative parameters, suggesting a key
role in heart failure progression.
A major focus of studies on acute heart failure is the
need for methods that allow the early detection of hemo-
dynamic variables that can be a key prognostic role after
cardiac surgery. F. Corradi et al. in their study investigated
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the Renal Doppler Resistive Index as a marker of oxygen
supply and demand mismatch in 61 postoperative cardiac
surgery patients. Interestingly, bymultivariate analysis, Renal
Doppler Resistive Index was significantly correlated with
mixed-venous oxygen saturation, suggesting that, inmechan-
ically ventilated patients after cardiac surgery, it could be used
as a marker of early vascular response to tissue hypoxia.
We must not forget that there are many patients suffer-
ing from heart failure secondary to extracardiac diseases.
Among the causes of heart failure, an important place
is held by cardiotoxicity due to antineoplastic treatments
that has emerged as a clinically relevant problem as a
consequence of the relevant improvement of survival after
cancer. In the last decade recent advances have emerged
in clinical and pathophysiological aspects of left ventricular
dysfunction induced by the most widely used anticancer
drugs. M. Molinaro et al., in their comprehensive review
entitled “Recent Advances on Pathophysiology, Diagnostic
and Therapeutic Insights in Cardiac Dysfunction Induced
by Antineoplastic Drugs,” have particularly examined the
role of early, sensitive markers of cardiac dysfunction, in
order to predict this form of cardiomyopathy before left
ventricular ejection fraction is reduced. It seems actually that
this is increasingly important issue, along with the evalu-
ation of novel therapeutic and cardioprotective strategies,
to protect cardiooncologic patients from the development
of congestive heart failure. As reported by A. Adegunsoye
et al., there are also a consistent number of patients who
die due to right heart failure and pulmonary hypertension
secondary to fibrotic lung diseases. Significant factors which
appear to play a role in the mechanism of progression of
right heart dysfunction include chronic hypoxia, defective
calcium handling, hyperaldosteronism, pulmonary vascular
alterations, cyclic strain of pressure and volume changes,
elevation of circulating TGF-𝛽, and elevated systemic NO
levels. The authors have reported an exhaustive review of
novel therapeutic strategies for reducing right heart failure
associated mortality in fibrotic lung diseases, because only
“an early, effective and individualized therapy may prevent
overt right heart failure in fibrotic lung disease leading to
improved outcomes and quality of life.”
Another major focus of studies on acute heart failure
is related to the evaluation of new surgical alternatives to
transplantation or new systems or new materials available
for future cardiac assist devices. In this special issue the
review of J. Anand et al. explores the evolution of mechanical
circulatory support and its potential for providing long-
term therapy, which may address the limitations of cardiac
transplantation.The innovation progresses have led to a solu-
tion of current challenges involving device complications.
Moreover outcomes continue to improve and further data
fromboth small and large registries help to advance evidence-
based practices: thus patients in the most advanced stages
of heart failure appear to have more hope than ever before.
On the other hand the high costs, expanding indications,
and rapidly increasing number of devices implanted will
ultimately require important decisions to be made on the
part of society, clinicians, and administrative agencies in
order to establish the potential amount of economic resources
to spend on this expensive, yet effective, therapy. Patient
selection will remain paramount, although a very large
population of patients will have the potential to benefit.
In particular, K. Unthan et al. reported a study on the
design and evaluation of a fully implantable control unit
for blood pumps. It is well known that pneumatic devices
sufficiently supply the patients with blood flow, although
the patient’s quality of life is limited by the percutaneous
pressure lines and the size of the external control unit.
General requirements for any implantable control unit are
defined from a technical and medical point of view: need for
a Transcutaneous Energy Transmission, autonomous opera-
tion, safety, geometry, and efficiency. The authors described
the development of the control unit of the ReinHeart, a fully
implantable Total Artificial Heart that, in validation tests,
is demonstrated to be a stable operation with a promising
good efficiency. Finally P. Morillas-Sendı´n et al. assessed
the effect of sevoflurane and propofol on organ blood flow
in a porcine model with a left ventricular assist device.
The authors demonstrated that, compared with propofol,
sevoflurane increases blood flow in the brain, liver, and heart
after implantation of a left ventricular assist device under
conditions of partial support, giving interesting indications
for the intensive pharmacological care of these high-risk
patients.
The modern approach to the diagnosis and treatment of
heart failure is multidisciplinary and should be based on a
close collaboration among researchers, clinicians, and cardiac
surgeons particularly given thatmandatorymultiorgan atten-
tion is required in these high-risk patients.
Future therapies for heart failure could include ventric-
ular assist devices implantation or ventricular restoration
techniques with the aim to obtain a reverse, positive remod-
eling in the unloaded heart. With an expanding “toolbox”
of comprehensive basic, medical, surgical, and technological
approaches, it is expected that these novel findings will soon
be translated to the clinical practice. In fact, new therapeutic
strategies are needed by the millions of patients suffering
from heart failure. We hope that this special issue will help
readers become familiarized with recent progress regarding
the diagnosis and treatment of heart failure.
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